Immuron Ltd has released a press release.
Immuron planned Acquisition of R&D Vaccine Company
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Immuron
- Preliminary Final Report
- Voluntary Suspension
- Pause in Trading
- IMM124E May Offer New Modality for Inhibition of SARS-CoV-2
- Immuron SARS-CoV-2 Research Agreement with Monash University
Later from Immuron
- IMM124E Demonstrates Antiviral T-Cell Immunity
- US DoD Naval Medical Research Center Clinical Update
- US DoD Travelan Clinical Update
- Immuron Receives European Patent on Drug to Treat Diarrhea
- Response to ASX Query
Follow Immuron into a list and get an email when it puts out news.
Follow Immuron